Cronos Group Inc.
Rank #462HypergrowthCRON · Nasdaq · Healthcare
Cronos Group Inc. (CRON) — Rank #462 by gross profitability (GP/assets 0.05) · ROE -0.9% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0001656472 · all metrics point-in-time as of the filing date.
About
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
Show moreShow less
It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
The company is headquartered in Stayner, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- State
- A1
- Filer Category
- Accelerated filer
- Fiscal Year End
- December 31
- Website
- thecronosgroup.com
Financials
Strengthening
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginimproving
- Gross profitabilityimproving
- Net cashdeteriorating
- Operating marginimproving
- Return on equityimproving
- Share count (dilution)improving
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-26 | 2024-12-31filed 2025-02-27 | 2023-12-31filed 2024-02-29 | 2022-12-31filed 2023-02-28 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 146.6 | 117.6 | 87.2 | 91.9 |
| Revenue growth (YoY) | 24.6% | 34.8% | 0.6% | 23.5% |
| Gross profit | 62.8 | 25.2 | 11.9 | 12.0 |
| Gross margin | 42.8% | 21.4% | 13.7% | 13.0% |
| Net income | (9.4) | 41.1 | (74.0) | (168.7) |
| Net margin | -6.4% | 34.9% | -84.8% | -183.6% |
| EPS (diluted) | -$0.02 | $0.11 | -$0.19 | — |
| EPS growth (YoY) | -118.2% | 157.9% | — | — |
| Cash flow | ||||
| Operating cash flow | 25.9 | 18.8 | (42.8) | (88.9) |
| Capital expenditures | 25.7 | 12.4 | 2.5 | 3.5 |
| Free cash flow | 0.1 | 6.4 | (45.3) | (92.4) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?